BCSFX | BCSVX | BCSFX / BCSVX | |
Total Expense Ratio | 1.06 | 1.31 | 81% |
Annual Report Gross Expense Ratio | 1.06 | 1.31 | 81% |
Fund Existence | 10 years | 10 years | - |
Gain YTD | 10.269 | 10.057 | 102% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 500000 | 5000 | 10,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.34B | 2.33B | 101% |
Annual Yield % from dividends | 0.00 | 0.00 | - |
Returns for 1 year | 16.83 | 16.57 | 102% |
Returns for 3 years | 34.93 | 33.98 | 103% |
Returns for 5 years | 27.48 | 25.81 | 106% |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SHSCX | 45.66 | 0.20 | +0.44% |
BlackRock Health Sciences Opps Inv C | |||
JNVMX | 18.74 | 0.03 | +0.16% |
JPMorgan Developed International ValueR6 | |||
EPDPX | 12.15 | 0.01 | +0.08% |
EuroPac International Dividend Income A | |||
IRCIX | 12.23 | -0.15 | -1.21% |
Voya Russell Small Cap Index Port S2 | |||
VIKSX | 11.26 | -0.16 | -1.40% |
Virtus KAR Small-Mid Cap Growth I |